comparemela.com

Latest Breaking News On - Fusion pharmaceuticals price performance - Page 1 : comparemela.com

Fusion Pharmaceuticals Inc. (NASDAQ:FUSN) Receives Average Recommendation of "Hold" from Brokerages

Fusion Pharmaceuticals Inc. (NASDAQ:FUSN) Receives Average Recommendation of "Hold" from Brokerages
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

New-york
United-states
Canada
Raymond-james
Renaissance-technologies
Nasdaq
Geode-capital-management
Analyst-recommendations-for-fusion-pharmaceuticals
Fusion-pharmaceuticals-inc
Institutional-investors-weigh-in-on-fusion-pharmaceuticals
Fusion-pharmaceuticals-price-performance
York-state-common-retirement-fund

Short Interest in Fusion Pharmaceuticals Inc. (NASDAQ:FUSN) Declines By 8.3%

Fusion Pharmaceuticals Inc. (NASDAQ:FUSN – Get Free Report) was the target of a significant drop in short interest during the month of March. As of March 15th, there was short interest totalling 7,920,000 shares, a drop of 8.3% from the February 29th total of 8,640,000 shares. Based on an average trading volume of 2,210,000 shares, […]

United-states
Canada
Raymond-james
Sphera-funds-management
Fusion-pharmaceuticals-price-performance
Yarbrough-capital
Hermes-inc
News-ratings-for-fusion-pharmaceuticals-daily
Nasdaq
Fusion-pharmaceuticals
Forefront-analytics
Fusion-pharmaceuticals-inc

Fusion Pharmaceuticals Inc. (NASDAQ:FUSN) Receives Consensus Recommendation of "Hold" from Brokerages

Fusion Pharmaceuticals Inc. (NASDAQ:FUSN) Receives Consensus Recommendation of "Hold" from Brokerages
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Canada
United-states
Leerink-partnrs
Raymond-james
Nasdaq
Perceptive-advisors
Hermes-inc
Fusion-pharmaceuticals-price-performance
Fusion-pharmaceuticals
Sphera-funds-management
Analyst-recommendations-for-fusion-pharmaceuticals
Fusion-pharmaceuticals-inc

Fusion Pharmaceuticals (NASDAQ:FUSN) Receives Hold Rating from Jonestrading

Jonestrading reaffirmed their hold rating on shares of Fusion Pharmaceuticals (NASDAQ:FUSN – Free Report) in a research note issued to investors on Wednesday morning, Benzinga reports. Several other research firms also recently weighed in on FUSN. Royal Bank of Canada reiterated a sector perform rating and issued a $21.00 target price (up previously from $16.00) […]

Canada
Wellington
New-zealand-general
New-zealand
United-states
Raymond-james
Analyst-recommendations-for-fusion-pharmaceuticals
Fusion-pharmaceuticals-company-profile
Jefferies-financial-group
News-ratings-for-fusion-pharmaceuticals-daily
Hermes-inc
Sphera-funds-management

Yarbrough Capital LLC Makes New $739,000 Investment in Fusion Pharmaceuticals Inc. (NASDAQ:FUSN)

Yarbrough Capital LLC Makes New $739,000 Investment in Fusion Pharmaceuticals Inc. (NASDAQ:FUSN)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United-states
Canada
William-blair
Fusion-pharmaceuticals-profile
Exchange-commission
Citadel-advisors
Fusion-pharmaceuticals-inc
Fusion-pharmaceuticals
News-ratings-for-fusion-pharmaceuticals-daily
Schonfeld-strategic-advisors
Renaissance-technologies
Jefferies-financial-group
© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.